Recent Updates
Recently added Catalysts
AMS

AMERICAN SHARED HOSPITAL SERVICES REPORTS 2004 THIRD QUARTER AND NINE MONTH RESULTS Operating Income Sets New Records on Higher Revenue San Francisco, CA

Key Takeaway: AMERICAN SHARED HOSPITAL SERVICES REPORTS 2004 THIRD QUARTER AND NINE MONTH RESULTS Operating Income Sets New Records on Higher Revenue San Francisco, CA, October 26, 2004 AMERICAN SHARED HOSPITAL SERVICES (AMEX,PCX:AMS), the leading provider of Gamma Knife radiosurgery servi

Full Press Release Details

AMERICAN SHARED HOSPITAL SERVICES
REPORTS 2004 THIRD QUARTER AND NINE MONTH RESULTS
Operating Income Sets New Records on Higher Revenue
San Francisco, CA, October 26, 2004 AMERICAN SHARED HOSPITAL SERVICES
(AMEX,PCX:AMS), the leading provider of Gamma Knife radiosurgery services,
today announced record operating income and higher revenue for the third
quarter and first nine months of 2004.
For the three months ended September 30, 2004, revenue increased 3% to
$4,136,000 from $4,011,000 for the third quarter of 2003. Operating income
rose 13% to a record $860,000 from $758,000 a year earlier. Net income
increased to $840,000, or $0.16 per diluted share, which included an income tax
benefit of $472,000 related to the exercise of previously expensed stock
options. For last year s third quarter, net income was $369,000, or $0.07 per
For the nine months ended September 30, 2004, the Company reported revenue of
$12,479,000, a gain of 6% compared to revenue of $11,785,000 for the same
period a year ago. Operating income grew 12% to a record $2,471,000 from
$2,197,000 last year. Net income increased to $1,599,000 or $0.31 per diluted
share. This compares to net income for the first nine months of 2003 of
$1,039,000, or $0.20 per diluted share.
Ernest A. Bates, M.D., Chairman and Chief Executive Officer, said, Based on
contracts in hand, over the next nine months we expect to increase the number
of Gamma Knife centers by 17%. We see many opportunities to continue to build
our Gamma Knife platform and to expand our business into the market for
radiosurgery of the body, a new and exciting growth opportunity for AMS.
Bates noted that the Company s strong operating results have allowed it to
increase the fourth quarter dividend by 6%, to $0.18 per share at an annual
rate, following the 6% dividend increase paid in the third quarter of 2004.
At September 30, 2004, AMS provided Gamma Knife radiosurgery services to 18
hospitals in the United States. Craig Tagawa, Chief Operating and Financial
Officer, said that three additional hospitals currently are scheduled to begin
Gamma Knife service through AMS over the next few quarters. Our Baptist of
East Tennessee Gamma Knife project is scheduled to open by January 2005.
Northern Westchester Hospital in Mt. Kisco, New York has received its
Certificate of Need approval and is anticipated to open late in the first
quarter of 2005. Mercy Health Center in Oklahoma City, our 21st Gamma Knife
project, is projected to begin operating in mid-2005, he said.
Tagawa noted that total treatments in the third quarter of 2004 increased 8%
compared to the third quarter of 2003. He said that treatments from Gamma
Knife units in operation more than one year decreased 4% compared to last
year s unusually high volume, reflecting normal fluctuations in disease
incidence and related factors. The pace of treatments has picked up
noticeably in the past couple of months, he said.
AMS has scheduled its conference call for 4:00 pm ET today. To participate in
the live call, dial (800) 446-1671 at least 5 minutes prior to the scheduled
start time. A simultaneous WebCast of the call may be accessed through the
Company s website, www.ashs.com, or through CCBN, www.companyboardroom.com. A
replay will be available for 30 days at these same internet addresses, or by
calling (888) 843-8996, pass code 10196953. The replay will also be available
American Shared Hospital Services is building a profitable medical services
company in an underserved niche turnkey technology solutions for advanced
radiosurgical procedures. The Company s core business is supplying hospitals
with the Gamma Knife a non-invasive treatment for malignant and benign
brain tumors, vascular malformations and trigeminal neuralgia (facial pain).
The Gamma Knife, the gold standard in radiosurgery, reduces surgical risk and
patient discomfort, resulting in a shorter hospital stay and lower risk of
complications. In most cases, Gamma Knife patients resume their normal
activities within a few days of treatment, compared to weeks or months for
patients who undergo conventional surgery. More than 250,000 patients
worldwide have already received this treatment. American Shared Hospital
Services is the world leader in providing Gamma Knife radiosurgery services.
Safe Harbor Statement
This press release may be deemed to contain certain forward-looking statements
with respect to the financial condition, results of operations and future plans
of American Shared Hospital Services, which involve risks and uncertainties
including, but not limited to, the risks of the Gamma Knife business and the
risks of developing its IMRT and The Operating Room for the 21st Century
programs. Further information on potential factors that could affect the
financial condition, results of operations and future plans of American Shared
Hospital Services is included in the filings of the Company with the Securities
and Exchange Commission, including the Company s Annual Report on Form 10-K for
the year ended December 31, 2003, its Quarterly Report on Form 10-Q for the
periods ended March 31, 2004 and June 30, 2004 and the definitive Proxy
Statement for the Annual Meeting of Shareholders held on June 17, 2004.
Contacts: American Shared Hospital Services
Ernest A. Bates, M.D., (415) 788-5300
Chairman and Chief Executive Officer
e.bates@ashs.com
Berkman Associaties
Neil Berkman, (310) 277-5162
President
info@berkmanassociates.com
AMERICAN SHARED HOSPITAL SERVICES
Selected Financial Data
Summary of Operations Data
Three months ended Sept. 30, Nine months ended Sept. 30,
2004 2003 2004 2003
Revenue $ 4,136,000 $ 4,011,000 $ 12,479,000 $ 11,785,000
Cost of operations 1,906,000 1,895,000 5,936,000 5,313,000
Gross margin 2,230,000 2,116,000 6,543,000 6,472,000
Selling administrative 817,000 702,000 2,345,000 2,367,000
Interest expense 553,000 656,000 1,727,000 1,908,000
Operating income 860,000 758,000 2,471,000 2,197,000
Interest other income 21,000 27,000 64,000 99,000
Minority interest (267,000 ) (224,000 ) (764,000 ) (699,000 )
Income before income taxes 614,000 561,000 1,771,000 1,597,000
Income tax (benefit) expense (226,000 ) 192,000 172,000 558,000
Net income $ 840,000 $ 369,000 $ 1,599,000 $ 1,039,000
Earnings per common share:
Basic $ 0.18 $ 0.10 $ 0.38 $ 0.27
Assuming dilution $ 0.16 $ 0.07 $ 0.31 $ 0.20
Basic shares 4,755,000 3,871,000 4,214,000 3,827,000
Diluted shares 5,119,000 5,081,000 5,097,000 5,072,000
9/30/2004 9/30/2003
Cash $ 9,512,000 $ 10,882,000
Restricted cash $ 50,000 $ 50,000
Current assets $ 13,106,000 $ 14,280,000
Total assets $ 46,158,000 $ 47,042,000
Current liabilities $ 8,154,000 $ 7,560,000
Shareholders equity $ 17,326,000 $ 15,143,000
Last updated: Oct 26, 2004